ReachMD

Popular

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Brian P. McDonough, MD, FAAFP

    Peer

  13

  

  RestartResume

  How Primary Care Clinicians on the Frontline Are Managing Patients During the...

• • 

    

    Javier Cortes, MD, PhD

    Peer

  • 

    

    Giuseppe Curigliano, MD, PhD

    Peer

  • 

    

    Peter Schmid, FRCP, MD, PhD

    Peer

  0

  

  RestartResume

  Applying Real-World Evidence to Improve Clinical Decision-Making for Patients...

• • 

    

    Joseph Lim, MD

    Peer

  • 

    

    Steven Flamm, MD

    Peer

  6

  

  RestartResume

  Management of the Patient with Chronic Hepatitis C

• • 

    

    John J. Russell, MD

    Peer

  11

  

  RestartResume

  Off-Label Medicines in Fighting COVID-19 & Through the Years

• • 

    

    Tom Corbridge, MD, FCCP

    Peer

  • 

    

    Gary Ferguson, MD, F.C.C.P

    Peer

  3

  

  RestartResume

  Impacts of Patients Underreporting COPD Exacerbations

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Marcia Ryder, PhD MS RN

    Peer

  4

  

  RestartResume

  Pearls & Pitfalls of Algorithm-Based Vascular Access Care Protocols

• • 

    

    Jacob Sands, MD

    Peer

  1

  

  RestartResume

  Next Generation Sequencing in Lung Squamous Cell Carcinoma

• • 

    

    Kevin Wilson, MD

    Peer

  16

  

  RestartResume

  COVID-19: Interim Guidance on Management Pending Empirical Evidence. From an ...

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Mauro Pittiruti, MD

    Peer

  7

  

  RestartResume

  COVID-Centered Updates to the GaVeCelt Recommendations for Vascular Access

• • 

    

    Spencer Greene, MD, MS, FACEP, FACMT, FAAEM

    Peer

  3

  

  RestartResume

  Navigating the Snake Bite Treatment Algorithm

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Hiren M. Shah, MD

    Peer

  • 

    

    Stanley C. Thompson, MD

    Peer

  2

  

  RestartResume

  Managing VTE in the Hospital Setting
• 5

  

  RestartResume

  Clinical Trial Data on an IBS-D Treatment

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lee Reichman, MD, MPH

    Peer

  0

  

  RestartResume

  Latent TB Screening Strategies for High-Risk Patient Populations

• • 

    

    Linda Bernstein, Pharm.D.

    Peer

  3

  

  RestartResume

  FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Ming-Sound Tsao, MD, FRCPC

    Peer

  4

  

  RestartResume

  How to Approach Liquid Biopsy in the Treatment of NSCLC